NCT04845113已完成不适用
Idiopathic Purpura Fulminans Associated With Anti-PS Antibodies in Children: a French Multicenter Retrospective Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Rate of anti-protein S antibody
研究概览
简要总结
Idiopathic purpura fulminans by anti-protein S antibody is a very rare but potentially extremely serious entity. The data in the literature are poor with only isolated report boxes and a single series of less than 10 boxes. The creation of a larger series of cases would make it possible to better understand this pathology and to offer assistance in diagnosis and management.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- — 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Rate of anti-protein S antibody
时间窗: 1 day
Rate of anti-protein S antibody
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Sepsis-Associated Purpura Fulminans International Registry - EuropeSepsisNCT02238795Jena University Hospital28
已完成
3 期
IGIV Study for Chronic ITP Patients Ages 3-70Idiopathic Thrombocytopenic PurpuraNCT00511147Grifols Biologicals, LLC64
招募中
不适用
Efficacy and Safety of Immunosuppression, Caplacizumab and Plasma Infusion Without Therapeutic Plasma Exchange in Immune-mediated Thrombotic Thrombocytopenic PurpuraThrombotic MicroangiopathiesNCT06291025University Hospital, Rouen131
进行中（未招募）
1 期
Eltrombopag With Standard Immunosuppression for Severe Aplastic AnemiaSevere Aplastic AnemiaNCT01623167National Heart, Lung, and Blood Institute (NHLBI)207
Unknown
3 期
Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP PatientsImmune Thrombocytopenic Purpura (ITP)NCT02877212National Institute of Blood and Marrow Transplant (NIBMT), Pakistan75